Lenograstim [lenograstim]
topical
- Terms
-
Neutrogin
-
Euprotin
Granocyte
Lenograstim, Component 1
Lenograstim, Component 2
Persistent link
https://www.medvik.cz/link/D000078224
Definition
A recombinant granulocyte colony-stimulating factor that is used to treat or prevent NEUTROPENIA in patients receiving myelosuppressive cancer chemotherapy, for the preparation and collection of blood progenitor cells in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; and in the treatment of severe congenital neutropenia. Component 1 and Component 2 differ by absence or presence of Neu5Ac in 2-6 linkage to GalNAc side chain.
- DUI
- D000078224 MeSH Browser
- CUI
- M0219654
- History note
- 2019 (1993)
- Public note
- 2019; LENOGRASTIM was indexed under GRANULOCYTE COLONY-STIMULATING FACTOR and RECOMBINANT PROTEINS 1993-2018
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AA
- analogs & derivatives
- AN
- analysis
- BI
- biosynthesis
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D09.400.430.775.200.750
Lenograstim
D12.644.276.374.410.240.350.750
Lenograstim
D12.776.395.240.200.750
Lenograstim
D12.776.467.374.410.240.350.750
Lenograstim
D23.529.374.410.240.350.750
Lenograstim